Efficacy and Safety of PD-1 Inhibitors and Targeted Drugs Combined with Radiotherapy in First-Line Treatment of Oligometastatic Hepatocellular Carcinoma

被引：0
|
作者：
Zhu, K. [1 ]
Liu, J. [2 ]
Dou, X. [1 ]
Zhang, X. [1 ]
Xu, L. [1 ]
Shi, P. [2 ]
Shi, F. [1 ]
Yue, J. [1 ]
机构：
[1] Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan, Peoples R China
[2] Shandong First Med Univ, Shandong Canc Hosp, Jinan, Shandong, Peoples R China
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2024年 / 120卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3126
引用
收藏
页码：E509 / E509
页数：1
相关论文
共 50 条
  • [41] Effectiveness and safety of PD-1/PD-L1 or CTLA4 inhibitors combined with chemotherapy as a first-line treatment for lung cancer: A meta-analysis
    Shen, Kaikai
    Cui, Jinggang
    Wei, Yuqing
    Chen, Xiaojun
    Liu, Guohua
    Gao, Xiaolai
    Li, Wei
    Lu, Huiling
    Zhan, Ping
    Lv, Tangfeng
    Lin, Dang
    JOURNAL OF THORACIC DISEASE, 2018, 10 (12) : 6636 - 6652
  • [42] A network comparison on efficacy and safety profiling of PD-1/PD-L1 inhibitors in first-line treatment of advanced non-small cell lung cancer
    Fu, Jie
    Yan, Yi-Dan
    Wan, Xu
    Sun, Xiao-Fan
    Ma, Xiu-Mei
    Su, Ying-Jie
    FRONTIERS IN PHARMACOLOGY, 2025, 15
  • [43] The efficacy and safety of donafenib combined with transcatheter arterial chemoembolization and anti-PD-1 antibodies as first-line therapy for hepatocellular carcinoma: A retrospective study
    Song, Danjun
    Hao, Weiyuan
    Cao, Fei
    Luo, Jun
    Guo, Liwen
    Zhang, Zhewei
    Zheng, Jiaping
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [44] The efficacy and safety of chemotherapy with or without anti-PD-1 for the first-line treatment of advanced urothelial carcinoma
    Han, Fuxin
    Wu, Zhaozhen
    Chen, Jiaxin
    Liu, Meicen
    Hu, Yi
    CANCER MEDICINE, 2023, 12 (23): : 21129 - 21137
  • [45] Efficacy of treatment based on TKIs in combination with PD-1 inhibitors for unresectable recurrent hepatocellular carcinoma
    Zhang, Ze
    Jiao, Tianyu
    Li, Junfeng
    Hu, Bingyang
    Zhang, Wenwen
    Wang, Zhijun
    Wan, Tao
    Wang, Yafei
    Lu, Shichun
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2023, 21 (01)
  • [46] Efficacy of treatment based on TKIs in combination with PD-1 inhibitors for unresectable recurrent hepatocellular carcinoma
    Ze Zhang
    Tianyu Jiao
    Junfeng Li
    Bingyang Hu
    Wenwen Zhang
    Zhijun Wang
    Tao Wan
    Yafei Wang
    Shichun Lu
    World Journal of Surgical Oncology, 21
  • [47] Interim efficacy and safety of PD-1 inhibitors in preventing recurrence of hepatocellular carcinoma after interventional therapy
    Qiao, Wenying
    Wang, Qi
    Hu, Caixia
    Zhang, Yinghua
    Li, Jianjun
    Sun, Yu
    Yuan, Chunwang
    Wang, Wen
    Liu, Biyu
    Zhang, Yonghong
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [48] Combined radiotherapy and transarterial chemoembolization as a first-line treatment for hepatocellular carcinoma with macroscopic vascular invasion.
    Yoon, Sang Min
    Joo, Ji Hyeon
    Jung, Jinhong
    Kim, Yeon Joo
    Park, Jin-Hong
    Kim, Jong Hoon
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [49] Real world data and biomarker analysis of the efficacy and safety of PD-1 inhibitor combined with chemotherapy in first-line treatment of advanced gastric cancer.
    Ma, Xiaoting
    Ou, Kai
    Yang, Wenwei
    Cao, Biyang
    Yang, Lin
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 342 - 342
  • [50] The efficacy and safety of cadonilimab combined with lenvatinib for first-line treatment of advanced hepatocellular carcinoma: A phase Ib/II clinical trial
    Bai, L.
    Bai, Y.
    Huang, M.
    Shao, G.
    Song, L.
    Sun, M.
    Wang, W.
    Wu, J.
    Xu, A.
    Huang, L.
    Liu, T.
    Liu, W.
    Wang, Z. M.
    Li, B.
    Xia, Y.
    ANNALS OF ONCOLOGY, 2023, 34 : S595 - S595
12345